We are live on
!
Find out more
DCP
DSM Capital Partners Portfolio holdings
AUM
$5.66B
1-Year Est. Return
27.45%
This Fund
S&P 500
This Quarter
Est. Return
+12%
1 Year Est. Return
+27.45%
3 Year Est. Return
+126.04%
5 Year Est. Return
+156.94%
10 Year Est. Return
+722.36%
AUM
$7.55B
AUM Growth
+$1.05B
(+16%)
Cap. Flow
+$245M
Cap. Flow
% of AUM
3.24%
Top 10 Holdings %
Top 10 Hldgs %
64.04%
Holding
53
New
2
Increased
36
Reduced
9
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$95.5M |
| 2 |
JD.com
JD
|
+$67.6M |
| 3 |
Automatic Data Processing
ADP
|
+$29.5M |
| 4 |
EPAM Systems
EPAM
|
+$26.2M |
| 5 |
Booking.com
BKNG
|
+$19.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MSCI
MSCI
|
+$110M |
| 2 |
Monster Beverage
MNST
|
+$60.4M |
| 3 |
Nice
NICE
|
+$3.6M |
| 4 |
Globant
GLOB
|
+$910K |
| 5 |
PagSeguro Digital
PAGS
|
+$851K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Consumer Discretionary | 19.84% |
| 3 | Communication Services | 15.37% |
| 4 | Healthcare | 14.19% |
| 5 | Financials | 12.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.45T
| $760M | 10.06% |
4,818,331
+110,324
| +2% | +$16.2M |
|
2
Alibaba
BABA
$293B
| $647M | 8.56% |
3,049,051
+64,859
| +2% | +$12.2M |
|
3
Adobe
ADBE
$99.5B
| $620M | 8.21% |
1,880,305
+37,074
| +2% | +$10.9M |
|
4
Alphabet (Google) Class A
GOOGL
$4.36T
| $556M | 7.36% |
8,302,420
+222,300
| +3% | +$14.3M |
|
5
Visa
V
$684B
| $460M | 6.08% |
2,445,924
+57,479
| +2% | +$10.4M |
|
6
Meta Platforms (Facebook)
META
$1.42T
| $438M | 5.8% |
2,135,860
+48,230
| +2% | +$9.34M |
|
7
PayPal
PYPL
$48.9B
| $387M | 5.13% |
3,580,945
+78,250
| +2% | +$8.15M |
|
8
Amazon
AMZN
$2.92T
| $335M | 4.44% |
3,630,500
+72,520
| +2% | +$6.42M |
|
|
9
Automatic Data Processing
ADP
$106B
| $292M | 3.87% |
1,714,437
+178,086
| +12% | +$29.5M |
|
10
Zoetis
ZTS
$32.4B
| $264M | 3.49% |
1,994,303
+68,011
| +4% | +$8.45M |
|
11
Becton Dickinson
BDX
$45.6B
| $207M | 2.74% |
780,982
+11,544
| +2% | +$2.88M |
|
|
12
Booking.com
BKNG
$149B
| $173M | 2.3% |
2,111,675
+246,500
| +13% | +$19.4M |
|
|
13
EPAM Systems
EPAM
$5.51B
| $173M | 2.29% |
815,626
+133,178
| +20% | +$26.2M |
|
14
Palo Alto Networks
PANW
$270B
| $166M | 2.2% |
4,306,188
+31,776
| +0.7% | +$1.2M |
|
15
Intuit
INTU
$86.5B
| $165M | 2.18% |
628,202
+69,924
| +13% | +$18.3M |
|
16
Abbott
ABT
$183B
| $149M | 1.97% |
1,714,491
+39,008
| +2% | +$3.27M |
|
17
SiriusXM
SIRI
$9.98B
| $146M | 1.93% |
2,043,070
+79,582
| +4% | +$5.36M |
|
18
Thermo Fisher Scientific
TMO
$213B
| $142M | 1.88% |
436,784
+10,945
| +3% | +$3.32M |
|
19
New Oriental
EDU
$9.37B
| $135M | 1.79% |
1,116,726
+140,238
| +14% | +$16.8M |
|
20
Burlington
BURL
$23.2B
| $134M | 1.78% |
589,148
+16,382
| +3% | +$3.42M |
|
21
Elanco Animal Health
ELAN
$13.2B
| $134M | 1.78% |
4,561,386
+673,481
| +17% | +$18.3M |
|
22
Royal Caribbean
RCL
$85.1B
| $134M | 1.77% |
1,002,770
+24,028
| +2% | +$2.8M |
|
23
Global Payments
GPN
$23B
| $116M | 1.54% |
636,470
+14,350
| +2% | +$2.46M |
|
|
24
Boston Scientific
BSX
$69.5B
| $103M | 1.37% |
+2,282,065
| New | +$95.5M |
|
|
25
Monster Beverage
MNST
$94.3B
| $98.1M | 1.3% |
3,086,530
-2,055,966
| -40% | -$60.4M |
|
Similar funds
F
RMDI
O
AC
CRC
ACM
PI
TSW
DSM Capital Partners's Q4 2019 Portfolio in Review
As of Q4 2019, DSM Capital Partners held 53 positions worth $7.55B, up 16% from $6.5B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
DSM Capital Partners deployed $245M of net new capital in Q4 2019, opening 2 new positions and adding to 36 existing holdings. Its largest new stake was Boston Scientific: 2,282,065 shares worth $103M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Monster Beverage, an estimated $60.4M trimmed.
- DSM Capital Partners's largest Q4 2019 buy was Boston Scientific: 2,282,065 shares worth $103M.
- DSM Capital Partners added most to JD.com in Q4 2019, an estimated $67.6M increase.
- DSM Capital Partners's biggest Q4 2019 reduction was Monster Beverage, cutting an estimated $60.4M.
- DSM Capital Partners fully exited MSCI in Q4 2019, selling an estimated $110M.
- DSM Capital Partners's ten largest holdings make up 64% of its $7.55B portfolio in Q4 2019.
- DSM Capital Partners opened 2 new positions and closed 5 in Q4 2019.
- DSM Capital Partners's portfolio value rose 16% quarter-over-quarter to $7.55B.
Based on DSM Capital Partners's 13F filing for Q4 2019, filed 13 Feb 2020.